P-0211 * PRESPECIFIED SUBGROUP ANALYSES IN WJOG4407G TRIAL, A RANDOMIZED PHASE III TRIAL OF MFOLFOX6 PLUS BEVACIZUMAB VERSUS FOLFIRI PLUS BEVACIZUMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER

Yahata Kensei,N Koji,Hyodo Ichinosuke,Boku Narikazu, Matsuoka Satoshi,A Masahiko, Sumiya Eiji,Tohjoh Fumio,O Toshio,T Keisei,E Masahide, H Tomonori,T Yasuo,S Mikio, Kubota Kentaro,S Nobuhiko,Sashino Kazuya, Okada Michio, Sato Koichi, Yasuhara Kentaro,T Hiroshi

Annals of Oncology(2014)

Cited 23|Views4
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined